FDA considers lifting safety limits on Avandia

FDA considers lifting safety limits on Avandia

For three years the FDA struggled to answer a seemingly simple question: Does Avandia increase the risk of heart attacks? A definitive answer has never been reached, in part because patients with diabetes are already predisposed to heart problems.

4
Like
Save

Comments

Write a comment

*